HLA-DQ Antibodies

Santa Cruz Biotechnology offers a broad range of HLA-DQ monoclonal antibodies for various research applications. HLA-DQ monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-DQ is a critical component of the human immune system, playing a vital role in the presentation of antigens to T cells and influencing immune responses. Understanding HLA-DQ expression and function is essential for research in autoimmune diseases and transplant rejection. HLA-DQ research continues to reveal new insights into disease mechanisms and potential therapeutic targets. Investigating HLA-DQ interactions helps researchers better understand immune system regulation and response. Exploring HLA-DQ pathways contributes to advancing immunological research and therapeutic development. HLA-DQ monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to make meaningful contributions to immunology research and therapeutic discoveries.